[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)
Covid-19

COVID-19

Understand the influence of COVID-19 on the CPAP Devices Market with our analysts monitoring the situation across the globe.

Market Overview

Continuously positive airway pressure devices (CPAP) are extensively used by the patients suffering from obstructive sleep apnea as they aid in collapsing the airway that may block the normal breathing activity among the patients.

The CPAP devices market was valued at USD 2,395.99 million in 2019 and is projected to grow with a CAGR of 7.4% during the forecast period.

CPAP-Devices-Market

Growing Global Burden of Sleep Apnea and Rising Government Initiatives

Globally, the demand for continuous positive airway pressure devices has been increasing at a steady pace, further offering a strong growth prospect for the market players during the forecast period. Sleep apnea leads to several health problems, including heart diseases, obesity, diabetes, and depression. Untreated sleep apnea, on the other hand, can lead to occupational injuries and a lack of job productivity. As per the Center for Disease Control and Prevention (CDC), more than 350 million people suffer from sleep apnea worldwide.

As per a 2016 report by the American Academy of Sleep Medicine (AASM), in the U.S., the annual economic burden incurred by undiagnosed sleep apnea was around USD 149.6 billion. Increasing awareness regarding sleep apnea and associated comorbid conditions is subsequently driving the adoption of continuous positive airway pressure devices. In addition to this, the governments across the globe have started focusing on the growing prevalence of obstructive sleep apnea and are formulating several programs to raise awareness about the condition, further driving the market growth.  

CPAP-Devices-Market-Growth

Rising Technological Advancements and Initiatives of Key Manufacturers

The advent of new technologies, such as an auto-adjusting system that enables the user to control the breathing habit and deliver the correct amount of pressure at the right moment with optimum ease, bolsters the market growth. CPAP devices are equipped with data-collecting features that enable health care practitioners to achieve greater and reliable clinical results. Thus, significant advancements in CPAP technology that are designed to enhance the therapy experience drive market growth.

The key manufacturers of airway pressure devices are actively working to improve their existing line of products in order to achieve a better compliance rate. The manufacturers are focusing on developing lightweight helmets with secure bands and smaller breathing helmets made of soft plastic.

Increasing the patient compliance rate propels the CPAP devices market growth. About 80% of the patients suffering from sleep apnea opt for CPAP therapy. Most of the insurance providers grant reimbursements only when a patient abides to the compliance standards for a specified period of time in the first 90 days trial period, further impacting the market growth.

CPAP Devices Market: Segmentation

Low Cost of CPAP Devices Drives Its Adoption among the End-Users 

The CPAP device segment holds the highest market share on account of rising doctor prescription for CPAP devices to treat the patients suffering from sleep apnea as the first line of therapy. The segment is also largely driven by the low cost of the devices and technological advancements, which is further driving its adoption across the end-users.

For instance, in January 2019, InnAccel launched the world’s first portable neonatal CPAP device, which is designed to offer support to critically-ill babies with respiratory distress syndrome (RDS). The product addresses over 160,000 annual deaths of premature babies in India caused by respiratory disorders.

Favorable Reimbursement Policies Bolsters the Hospital Segment

Hospitals across the globe carter to a large patient pool suffering from sleep disorders, which is a significant factor driving the hospital segment. The hospital segment is projected to hold the largest market share on account of the increasing number of private hospitals and favorable reimbursement policies. In 2017, there were around 4,700 sleep centers in the U.S. with a bed count of 7 to 8 beds in every lab. The home care setting segment, on the other hand, is projected to witness considerable growth on account of increasing demand for CPAP devices for home use.

Regional Overview

North-America-Lead-CPAP-Devices-Market

North America’s CPAP Devices Market Backed by Favorable Reimbursement Policies and Presence of Key Market Players

North America held the largest share in the CPAP devices market in 2019 and is projected to dominate the market during the forecast period. The region is backed by the presence of robust healthcare facilities and key healthcare players that are heavily investing in R&D activities to address the growing prevalence of sleep apnea. As per the American Sleep Association, in the U.S., around 50–70 million people suffer from different forms of sleep disorder every year. Whereas, in Canada, around 5.4 million people suffered from sleep apnea or were at higher risk of developing obstructive sleep apnea (OSA) in 2014, as per the Canadian Respiratory Journal.

In the U.S., favorable reimbursement policies offered by insurance providers, such as Medicare, strongly support the CPAP device market growth in the country. For instance, Medicare and other private insurance companies cover about 80% of the CPAP device expenses, further driving its adoption across several end-users. Apart from this, the rising prevalence of diabetes and obesity prompts the dire need for efficient CPAP devices across the region.

Rapidly Developing Healthcare Facilities and Burgeoning Healthcare Spending in Asia-Pacific

Asia-Pacific is projected to exhibit the fastest growth in the CPAP devices market on account of rapidly developing healthcare facilities, burgeoning healthcare spending, increasing R&D activities, and surging demand for technologically advanced CPAP devices in countries such as India and South Korea.

Increasing incidence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), tuberculosis, asthma, and sleep apnea, rapid technological advancements, and surging geriatric population drives the market growth. As per the Economic and Social Commission for Asia and the Pacific (ESCAP), in 2019, the geriatric population in the region reached 548 million. The governments are actively working to raise awareness and are organizing education campaigns such as the ‘Safe Lung Initiative,’ further driving the market growth.

Key Players

  • Medtronic Plc.
  • Smiths Group plc.
  • Koninklijke Philips N.V.
  • Draegerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare
  • Hamilton Medical AG
  • ResMed Inc.
  • DeVilbiss Healthcare LLC.
  • 3B Medical, Inc.
  • BMC Medical Co. Ltd.

Recent Developments

  • In April 2019, ResMed launched AirFit N30i, its first top-of-head-connected nasal CPAP mask across the U.S. with a newly designed nasal cradle cushion that sits under the wearer’s nose
  • In 2016, Koninklijke Philips (the Netherlands) launched its Dream Family solution, which comprises a DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app

CPAP Devices Market Segmentation

By Product

  • CPAP Devices
  • CPAP Humidifier
  • CPAP Masks
  • Accessories

By End-User

  • Hospital
  • Clinic
  • Sleep Centre
  • Home Care Setting

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Central andSouth America and the Caribbean
  • The Middle-East and Africa

Frequently Asked Questions (FAQs)

In 2019 Global CPAP Devices Market was valued at USD 2,395.99 million.
Increasing awareness regarding sleep apnea and associated comorbid conditions, rising technological advancements, and initiatives of key manufacturers are the key factors expected to drive CPAP Devices Market during the forecast period.
North America is expected to hold the highest market share in CPAP Devices Market.
Medtronic Plc., Smiths Group plc., Koninklijke Philips N.V., Draegerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, Hamilton Medical AG, ResMed Inc., DeVilbiss Healthcare LLC. are the top players in CPAP Devices Market.
The CPAP devices market was valued at USD 2,395.99 million in 2019 and is projected to grow with a CAGR of 7.4% during the forecast period.
CPAP Device Segment is expected to be a leading segment in CPAP Devices Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.


Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports